Conclusion: Vaccines prepared from the PCSK9-003 epitope peptide (F-A-Q-S-I-P-W-N) conjugated with Qb virus-like particles are suggested to be promising for atherosclerosis treatment by reducing LDL-C and improving other lipid profiles. This evidence concerns the gene PCSK9 and atherosclerosis.